0 Σχόλια
0 Μοιράστηκε
446 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
US Dietary Supplements Market Research Study on Preventive Healthcare AdoptionConsumer shopping behaviors are evolving, and nowhere is this more evident than in the dietary supplements sector. Today, online channels have become one of the most powerful growth drivers for supplement brands in the United States. With increasing reliance on e-commerce platforms and direct-to-consumer sales, purchasing supplements has never been more convenient. According to insights from...0 Σχόλια 0 Μοιράστηκε 4χλμ. Views 0 Προεπισκόπηση
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Σχόλια 0 Μοιράστηκε 8χλμ. Views 0 Προεπισκόπηση
-
“Molecular Biological Reagents Market to Reach US$ 18,230 Million | 9.0% CAGR Growth”Molecular Biological Reagents market was valued at US$ 10,120 million in 2024 and is projected to reach US$ 18,230 million by 2031, expanding at a robust compound annual growth rate (CAGR) of 9.0% during the forecast period. This sustained growth highlights the critical role molecular biological reagents play across healthcare, life sciences research, and biotechnology...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
“Molecular Biological Reagents Market to Reach US$ 18,230 Million | 9.0% CAGR Growth”Molecular Biological Reagents market was valued at US$ 10,120 million in 2024 and is projected to reach US$ 18,230 million by 2031, expanding at a robust compound annual growth rate (CAGR) of 9.0% during the forecast period. This sustained growth highlights the critical role molecular biological reagents play across healthcare, life sciences research, and biotechnology...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Adjunctive Hemostats Market to Reach USD 2.7 Billion by 2030 | CAGR 5.9%According to a newly published market research report by 24LifeSciences, global adjunctive hemostats market was valued at USD 1.8 billion in 2023 and is projected to reach USD 2.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period 20242030. Adjunctive hemostats are medical devices designed to control bleeding during surgical procedures when...0 Σχόλια 0 Μοιράστηκε 4χλμ. Views 0 Προεπισκόπηση
-
Aging Population Fuels Growth in Low Vision Magnifier Market, Forecast to Expand at 4.4% CAGRAccording to a new report from Intel Market Research, the global Low Vision Magnifier market was valued at USD 288 million in 2025 and is projected to reach USD 399 million by 2034, growing at a steady CAGR of 4.4% during the forecast period (2026-2034). This growth trajectory reflects the increasing global demand for assistive technologies coupled with demographic shifts toward an aging...0 Σχόλια 0 Μοιράστηκε 3χλμ. Views 0 Προεπισκόπηση
-
Air Driven Handpiece Turbines Market to Reach USD 2.1 Billion by 2032 | CAGR 6.8%According to a newly published market research report by 24LifeSciences, global air driven handpiece turbines market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2025-2032. Air driven handpiece turbines are precision dental instruments that operate at high...0 Σχόλια 0 Μοιράστηκε 3χλμ. Views 0 Προεπισκόπηση
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Σχόλια 0 Μοιράστηκε 4χλμ. Views 0 Προεπισκόπηση
-
Bovine Respiratory Disease Treatment Market to Reach USD 133 Million by 2031 | CAGR 19.6%According to a newly published market research report by 24LifeSciences, the global bovine respiratory disease treatment market was valued at USD 39 million in 2024 and is projected to reach USD 133 million by 2031, growing at a compound annual growth rate (CAGR) of 19.6% during the forecast period 2025-2031. Bovine Respiratory Disease (BRD), also known as shipping fever or feedlot pneumonia,...0 Σχόλια 0 Μοιράστηκε 3χλμ. Views 0 Προεπισκόπηση
-
Bovine Respiratory Disease Treatment Market to Reach USD 133 Million by 2031 | CAGR 19.6%According to a newly published market research report by 24LifeSciences, the global bovine respiratory disease treatment market was valued at USD 39 million in 2024 and is projected to reach USD 133 million by 2031, growing at a compound annual growth rate (CAGR) of 19.6% during the forecast period 2025-2031. Bovine Respiratory Disease (BRD), also known as shipping fever or feedlot pneumonia,...0 Σχόλια 0 Μοιράστηκε 3χλμ. Views 0 Προεπισκόπηση
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Σχόλια 0 Μοιράστηκε 4χλμ. Views 0 Προεπισκόπηση1
-
Competitive Landscape of the Performance Enhancing Drugs MarketGrowing demand for endurance improvement solutions is influencing pharmaceutical development strategies.New drug delivery technologies are enhancing safety and efficacy.Expanding clinical trials are expected to create future growth opportunities. The Performance Enhancing Drugs Market The market is projected to grow at a CAGR of 7.2% from 2025 to 2031, with valuation expected to expand from US$...0 Σχόλια 0 Μοιράστηκε 6χλμ. Views 0 Προεπισκόπηση
-
CRPS Market Growth Opportunities in the Global Pain Management SectorContinuous advancements in medical research are playing an important role in shaping the CRPS treatment market. Scientists are exploring innovative therapies aimed at reducing inflammation and nerve damage associated with the disorder. These research initiatives are expected to drive future market developments. The Complex Regional Pain Syndrome (CRPS) Market is projected to grow steadily...0 Σχόλια 0 Μοιράστηκε 5χλμ. Views 0 Προεπισκόπηση2
Αναζήτηση αποτελεσμάτων